# LinkZill

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/linkzill

- Industry: Semiconductors
- Headquarters: Hangzhou, China
- Website: www.linkzill.com
- Latest round: Series A (Feb 14, 2025)
- Investors on record: 1

## About

Established in 2019 and based in Hangzhou, China, Hangzhou Lingzhi Technology Co., Ltd., trading as LinkZill, operates as a biochip developer that mainly provides TFT biochips and TFT standardized products. It has a TFT semiconductor R&D center in Hangzhou and a R&D and marketing center in Cambridge, UK. The company has obtained the national high-tech enterprise certification and Zhejiang Province's specialized, refined and innovative small and medium-sized enterprise certification. The founder and CEO of the company, Linrun Feng graduated from Shanghai Jiaotong University and was the Vice President of NeuDrive in UK. In January 2026, LinkZill raised a venture funding from Proxima Ventures, Mingxian Investment Management and ZhenPartnersVI(HK)Limited.
The company mainly provides TFT biochip platform. Products include TFT biochips and TFT customized and standardized products. TFT biochips can be used in high-throughput DNA synthesis, digital microfluidics DMF, biological signal sensing and other application scenarios. TFT standardized products include portable resistance measurement system (Zhi Box 01RC), portable current measurement system (Zhi Box 02CM), and portable semiconductor electrical test and analysis system (Zhi Box TFT-IV0). Zhi Box 01RC is suitable for scenarios such as sports health monitoring and biomedical testing.

The company generates revenue by providing TFT biochips and TFT customized and standardized products.

The company will use the series A funding to accelerate the delivery of TFT life science products and global market expansion.

## Funding rounds

- Series A, Feb 14, 2025 — Proxima Ventures

## Investors

- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Series A